Old Web
English
Sign In
Acemap
>
authorDetail
>
Ricardo Garcia‐Sanchez
Ricardo Garcia‐Sanchez
AstraZeneca
Saxagliptin
Dapagliflozin
Medicine
Endocrinology
Type 2 diabetes
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial
2020
Diabetes, Obesity and Metabolism
Juan P. Frias
Guillermo Gonzalez‐Galvez
Eva Johnsson
Jill Maaske
Marcia A. Testa
Donald C. Simonson
Nalina Dronamraju
Ricardo Garcia‐Sanchez
Anne L. Peters
Show All
Source
Cite
Save
Citations (3)
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
2020
Diabetes, Obesity and Metabolism
Lars Johansson
Paul D. Hockings
Eva Johnsson
Nalina Dronamraju
Jill Maaske
Ricardo Garcia‐Sanchez
John P H Wilding
Show All
Source
Cite
Save
Citations (11)
Regulierung von Dapagliflozin-assoziierten Genitalinfektionen durch Saxagliptin: eine gepoolte Verträglichkeitsanalyse
2019
S. Del Prato
Eva Johnsson
Ricardo Garcia‐Sanchez
C Morgan
Peter Sartipy
Raisa Kurlyandskaya
Nayyar Iqbal
Chantal Mathieu
K Rohwedder
Show All
Source
Cite
Save
Citations (0)
Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes
2019
Diabetes, Obesity and Metabolism
Julio Rosenstock
Shira Perl
Eva Johnsson
Ricardo Garcia‐Sanchez
Stephan Jacob
Show All
Source
Cite
Save
Citations (7)
1